Is Nurix Therapeutics (NRIX) the Worst ARK Stock to Buy According to Short Sellers?
We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...
Nurix Therapeutics price target raised to $35 from $30 at H.C. Wainwright
H.C. Wainwright analyst Robert Burns raised the firm’s price target on Nurix Therapeutics (NRIX) to $35 from $30 and keeps a Buy rating on the ...
Decoding 9 Analyst Evaluations For Nurix Therapeutics
During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics NRIX, revealing diverse outlooks from ...
Massachusetts Financial Services Co. MA Decreases Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX)
Massachusetts Financial Services Co. MA lowered its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 29.3% ...
Insider Monkey7d
Why Is Nurix Therapeutics, Inc. (NRIX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
In this article, we are going to take a look at where Nurix Therapeutics, Inc. (NASDAQ:NRIX) stands against the other small-cap biotech stocks. The biotechnology sector is expanding quickly due to ...
Yahoo Finance16d
Nurix Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage ...
abc2724d
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 Data demonstrate potential superiority of a ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Nurix Therapeutics (NRIX), ARS Pharmaceuticals (SPRY) and Dexcom (DXCM)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nurix Therapeutics (NRIX – Research Report), ...
Yahoo Finance10d
Nurix Therapeutics, Inc. (NRIX)
SAN FRANCISCO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat ...